Position in HEPA
as of Mar 31, 2025
· filed May 15, 2025
Position Value
$7,046
New position
Shares Held
16,387
first reported quarter
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $417,111,756 across 199 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,633 | $42,560,800 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
3,925,446 | $30,108,170 | |
| 3 | EXEL |
Exelixis, Inc.
|
460,585 | $19,754,490 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
252,250 | $18,941,452 | |
| 5 | MRNA |
Moderna, Inc.
|
368,421 | $18,715,786 | |
| 6 | ARGX |
Argenx SE
|
18,754 | $13,695,108 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
613,229 | $12,847,147 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
3,486,299 | $12,236,909 |
All Filings in HEPA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-03-31 | $7,046 | 16,387 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||